Aug 6 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES Q2 2020 FINANCIAL RESULTS
* QTRLY REVENUE WAS $12.6 MILLION COMPARED TO $13.6 MILLION IN Q2 2019
* Q2 LOSS PER SHARE $0.20
* PRESIDENT AND COO GILBERT GODIN HAS BEEN APPOINTED TO SUCCEED CEO GREG GUBITZ WHO WILL RETIRE ON OCTOBER 1, 2020